NGVL: RETROVIRAL VECTOR PRODUCTION FOR CLINICAL USE

NGVL：用于临床用途的逆转录病毒载体生产

• 批准号: 7389879
• 负责人: KENNETH CORNETTA
• 金额: $ 36.86万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7389879
• 关键词: NGVL; RETROVIRAL; VECTOR; PRODUCTION; CLINICAL

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. CLINCAL GRANT MATERIAL WILL BE GENERATED WHICH MEETS FDA SPECIFICATIONS.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。将生成符合FDA质量标准的材料。